Trends & Forecasts

How can pharma improve patient access to medications? Christine Marsh of Boehringer Ingelheim offers her view.

Why we need to shift from reactive to proactive measures in tackling global health challenges.

The pipeline of early-stage CRISPR therapeutics is huge, but advancing these innovations will require a multifaceted strategy.

An HBV gene editing clinical trial has been approved in Moldova, but the challenges go beyond science and industry.

New techniques in solid state chemistry are transforming the pharmaceutical landscape in drug formulation and delivery.

How AI-driven process optimization could lower costs and improve success rates in drug development.

Claus Zieler from Astellas and EFPIA addresses the challenges facing innovation in Europe, including regulatory burdens and access to medicines.

As world leaders commit to an ambitious reduction in AMR-related deaths, we ask is five years enough time to achieve it?

How will the biopharma industry evolve over the next 10 years? We speak with experts from Sartorius and the USP.

PicnicHealth Co-founder and CEO Noga Leviner foresees AI as the augur of greater observational research